Painful rejection and other social ills prompt the same opioid response in the brain as physical pain, according to new in vivo PET neuroimaigng of snubbed subjects. 

Once limited to research novelty, PET/MR has expanded significantly, and in particular in neuroimaging applications and oncologic use—especially for imaging head and neck tumors, according to a review in the September issue of Current Radiology Reports.

Healthy elderly patients with hardened arteries were up to four times more likely to have amyloid plaque in the brain, according to research published Oct. 16 in Neurology.

Dose-intensification of systemic cancer therapy with I-131 metaiodobenzylguanidine (I-131 MIBG) may be ideal for palliative treatment of neuroendocrine tumors, according to a study published Oct. 7 in the Journal of Nuclear Medicine.

North American Spine Society (NASS) adds advanced medical imaging for some back pain to list of questionable procedures kept by the American Board of Internal Medicine (ABIM) Choosing Wisely initiative

Recognizing that one of the obstacles to getting x-ray access to patients in developing nations is simply knowledge, the Rotary Club of Park Ridge, Ill, has put the information and experience it has gathered installing x-ray rooms in Africa, Central Europe, Latin America and the Caribbean online in a free library resource

There is growing interest in applying molecular imaging techniques for the detection of peripheral vascular disease (PVD). A range of scanner-tracer combinations can be used for perfusion, angiogenesis and atherosclerotic imaging, according to a review published online Oct. 7 in the Journal of Nuclear Medicine.

An estimated 30 percent of epileptics experience drug resistance. A PET agent may one day be used to track physiological mechanisms of resistance, according to a study published online Oct. 3 in the Journal of Nuclear Medicine.